Greenlight Biosciences Holdings PBC (GRNA) Financials

$0.30

$0.00 (0.00%)

As on 27-Jul-2023 09:30EDT

Market cap

$45 Mln

Revenue (TTM)

$10 Mln

P/E Ratio

--

P/B Ratio

2.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	10.20	6.38	--	0.96	3.00	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	10.20	6.38	--	0.96	3.00	--
Operating Expenses	164.68	169.34	108.56	53.25	32.20	--
Operating Profit (EBIT)	-155.43	-163.92	-108.56	-52.28	-29.20	--
Other Income	-0.79	-2.04	--	--	--	--
Profit before Tax	-156.23	-165.96	-112.31	-53.25	-28.65	--
Provision for Tax	1.85	1.09	2.42	1.03	0.32	--
Profit after Tax (Net Income)	-158.07	-167.06	-114.73	-54.28	-28.97	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-157.32	-167.06	-129.76	-53.25	-37.15	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	21.94	48.06	-29.98	-138.82	-86.62	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	60.57	64.98	30.69	238.74	111.51	--
Current Liabilities	31.19	35.56	62.34	13.91	5.73	--
Total Liabilities	144.88	148.60	63.06	113.83	30.61	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	75.99	77.29	29.28	16.73	4.15	--
Current Assets	37.70	71.31	33.78	97.10	26.46	--
Total Assets	144.88	148.60	63.06	113.83	30.61	--
Total Debt*	77.43	80.48	66.08	18.90	1.57	--
Net Current Assets	6.51	35.75	-11.79	83.19	20.74	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-136.73	-91.83	-46.60	-25.64	--
Cash Flow from Investing Activities	--	-26.51	-15.04	-10.05	-1.90	--
Cash from Financing Activities	--	200.85	43.53	125.85	13.32	--
Net Cash Inflow / Outflow	--	37.61	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.18	-1.27	-0.93	-0.56	--	--
Cash EPS ($)	--	-1.20	-0.89	-0.55	--	--
Adjusted Book Value ($)	--	0.36	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.04	-0.75	-0.48	--	--
Free Cash Flow per Share ($)	--	-1.24	-0.87	-0.59	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-202.93	273.74	52.96	--	--
ROE (%)	-299.07	-1,847.24	135.94	48.15	--	--
ROA (%)	-106.51	-157.86	-129.72	-75.16	--	--
EBIT Margin (%)	-1,523.25	-2,567.65	--	-5,434.93	-973.08	--
Net Margin (%)	-1,679.65	-3,849.19	--	-5,642.31	-965.21	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	3,870.43	--	-1.00	-0.68	--	--
EBIT Growth (%)	-100.00	-51.00	-107.63	-79.04	--	--
Net Profit Growth (%)	-391.71	-45.61	-111.37	-87.39	--	--
EPS Growth (%)	-185.39	-0.36	-0.66	--	--	--
Book Value Growth (%)	-74.26	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.93	--	--	--	--
Price / Book Value	2.14	3.24	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.84	-1.09	--	--	--	--
Close Price ($)	0.43	1.18	--	--	--	--
High Price ($)	11.34	15.80	--	--	--	--
Low Price ($)	0.32	1.00	--	--	--	--
Market Cap ($ Cr)	45.43	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.49	1.67	-2.20	-0.14	-0.02	--
Short term debt to equity ratio	0.81	0.35	-1.30	0.00	-0.01	--
Current Ratio	1.21	2.01	0.54	6.98	4.62	--
Quick Ratio	1.21	--	--	--	--	--
Interest Coverage	-37.51	-39.76	-44.88	-50.86	-92.12	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.07	0.06	--	0.01	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.